Table 1.

MS cohort demographic/clinical features at baseline (prior to DMF treatment).

Sex	Age (years)	Prior DMT	Prior steroids (days prior to collection)	EDSS at baseline	EDSS at 6 months
M	23	Naive	312	1	1
M	40	Naive	7	3	3
M	35	Naive	54	1.5	1.5
F	32	Naive	3400	2.5	2.5
F	42	(Fingolimod)	1224	3	3
F	31	(Glatiramer acetate)	72	1.5	1.5
F	43	(Peginterferon beta-1a,interferon beta-1a)	95	2	2

MS: multiple sclerosis; DMF: dimethyl fumarate; DMT: disease-modifying therapy; EDSS: Expanded Disability Scale Status.